Core Viewpoint - The stock price of Sihuan Pharmaceutical (00460) has decreased by 5.13% as of August 19, with a trading price of 1.48 CNY per share and a transaction volume of 96.40 million CNY [1]. Group 1: Company Overview - Sihuan Pharmaceutical Holdings Group Co., Ltd. is a leading pharmaceutical company in China's prescription drug market, primarily engaged in the production and sales of cardiovascular prescription drugs [1]. - Since 2007, the company has been the largest supplier of cardiovascular prescription drugs in the country [1]. - Key operational data includes a unique sales model, a nationwide sales network, a diversified product portfolio, and strong research and development capabilities [1]. Group 2: Financial Performance - As of the 2024 annual report, Sihuan Pharmaceutical reported total revenue of 1.901 billion CNY and a net profit of -217 million CNY [2].
四环医药(00460)下跌5.13%，报1.48元/股